DE602004024299D1 - Vitronectin rezeptorantagonisten und ihre verwendung als radiopharmazeutika - Google Patents

Vitronectin rezeptorantagonisten und ihre verwendung als radiopharmazeutika

Info

Publication number
DE602004024299D1
DE602004024299D1 DE602004024299T DE602004024299T DE602004024299D1 DE 602004024299 D1 DE602004024299 D1 DE 602004024299D1 DE 602004024299 T DE602004024299 T DE 602004024299T DE 602004024299 T DE602004024299 T DE 602004024299T DE 602004024299 D1 DE602004024299 D1 DE 602004024299D1
Authority
DE
Germany
Prior art keywords
radiophoretic
agents
receptor antagonists
vitronectin receptor
targeting moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004024299T
Other languages
English (en)
Inventor
Thomas D Harris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lantheus Medical Imaging Inc
Original Assignee
Lantheus Medical Imaging Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lantheus Medical Imaging Inc filed Critical Lantheus Medical Imaging Inc
Publication of DE602004024299D1 publication Critical patent/DE602004024299D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545—Heterocyclic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Acoustics & Sound (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE602004024299T 2003-05-12 2004-05-12 Vitronectin rezeptorantagonisten und ihre verwendung als radiopharmazeutika Expired - Fee Related DE602004024299D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46972803P 2003-05-12 2003-05-12
US84286204A 2004-05-11 2004-05-11
PCT/US2004/014846 WO2004100996A1 (en) 2003-05-12 2004-05-12 Vitronectin receptor antagonist compounds and their use in the preparation of radiopharmaceuticals

Publications (1)

Publication Number Publication Date
DE602004024299D1 true DE602004024299D1 (de) 2010-01-07

Family

ID=33457156

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004024299T Expired - Fee Related DE602004024299D1 (de) 2003-05-12 2004-05-12 Vitronectin rezeptorantagonisten und ihre verwendung als radiopharmazeutika

Country Status (8)

Country Link
US (1) US20060217292A1 (de)
EP (1) EP1622647B1 (de)
JP (1) JP2007505155A (de)
AT (1) ATE449614T1 (de)
CA (1) CA2525396A1 (de)
DE (1) DE602004024299D1 (de)
MX (1) MXPA05012109A (de)
WO (1) WO2004100996A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2695384A1 (en) * 2007-07-31 2009-02-05 Burnham Institute For Medical Research Bi-dentate compounds as kinase inhibitors
JP5602939B2 (ja) 2010-04-12 2014-10-08 クゥアルコム・インコーポレイテッド ネットワークにおける低オーバーヘッド通信のためのデリミタの提供
US10555947B2 (en) * 2017-05-19 2020-02-11 Ocugen, Inc. Ophthalmic compositions and methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010042288A (ko) * 1998-03-31 2001-05-25 블레어 큐. 퍼거슨 신생혈관 형성 질환의 영상화용 약제
EP1140204A2 (de) * 1998-12-18 2001-10-10 Du Pont Pharmaceuticals Company Vitronektin-rezeptor antagonist arzeimittheln
EP1140864A2 (de) * 1998-12-18 2001-10-10 Du Pont Pharmaceuticals Company Pharmazeutische zusammensetzungen, vitronectinrezeptor antagonisten enthaltend
EP1140203B1 (de) * 1998-12-18 2007-05-23 Bristol-Myers Squibb Pharma Company Vitronektin rezeptor antagonist arzneimitteln oder diagnostika
EP1307226B1 (de) * 2000-06-21 2008-11-19 Lantheus Medical Imaging, Inc. Vitronectin rezeptor antagonist pharmaka
US20020122768A1 (en) * 2000-07-06 2002-09-05 Shuang Liu Stable radiopharmaceutical compositions and methods for preparation thereof
US7138104B2 (en) * 2001-08-08 2006-11-21 Bristol-Myers Squibb Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent

Also Published As

Publication number Publication date
ATE449614T1 (de) 2009-12-15
US20060217292A1 (en) 2006-09-28
WO2004100996A1 (en) 2004-11-25
JP2007505155A (ja) 2007-03-08
MXPA05012109A (es) 2006-02-08
EP1622647B1 (de) 2009-11-25
EP1622647A1 (de) 2006-02-08
CA2525396A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
ATE496051T1 (de) Pyrazolotetrahydropyridinderivate als orexinrezeptorantagonisten
ATE411323T1 (de) Cgrp-rezeptorantagonisten
ATE413400T1 (de) Cgrp-rezeptorantagonisten
DE122012000018I1 (de) Benzimidazolderivate und ihre verwendung als antagonisten des a II rezeptors.
ATE286897T1 (de) Morpholinderivate als antagonisten an orexinrezeptoren
ATE429427T1 (de) Pyrimidinderivate als orexin-rezeptorantagonisten
DE60228487D1 (de) Ethylenediaminderivate und ihre verwendung als orexinrezeptorantagonisten
DK1951660T3 (da) Histamin-3-receptorantagonister
ATE537170T1 (de) Cgrp-rezeptorantagonisten
ATE484505T1 (de) 5-sulfanylmethylä1,2,4ütriazolä1,5-aüpyrimidin- - olderivate als cxcr2-antagonisten
MA28631B1 (fr) Antagonistes des recepteurs muscariniques de l'acetylcholine
ATE414074T1 (de) 2-oxo-1,2,4,5-tetrahydro-1,3-benzdiazepin-3-yl- piperidine als cgrp-antagonisten
ATE503755T1 (de) Cgrp-rezeptorantagonisten
DE602004027998D1 (de) Kondensierte n-heterozyclische verbindung und ihre verwendung als crf-rezeptor antagonist
EA200500520A1 (ru) Пуриновые соединения и их применение в качестве лигандов каннабиноидных рецепторов
DE602005020655D1 (de) Carboxamid-spirolactam-cgrp-rezeptor-antagonisten
DE60331751D1 (de) N-substituierte 2-oxodihydropyridinderivate als npy antagonisten
DE60320529D1 (de) Chinolinderivate als npy antagonisten
DE60222647D1 (de) Urea derivate als integrin alpha 4 antagonisten
MA28363A1 (fr) Antagonistes des recepteurs muscariniques de l'acetylcholine
ATE466860T1 (de) Cgrp-rezeptorantagonisten
NO20024932D0 (no) Kontrastmiddel
ATE429428T1 (de) Indanderivate als antagonisten des mch-rezeptors
DE602005027870D1 (de) Cgrp-rezeptorantagonisten
CR10303A (es) "derivados de quinolina y su uso com pesticidas"

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee